APA
Flanders S. C., Kim J., Wilson S., Braziunas J., Greenfield S., Billimek J., Lechpammer S., Lin D. W., Karsh L., Quinn D. I., Shevrin D., Shore N. D., Symanowski J. T. & Penson D. F. (20180816). Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET. : Future oncology (London, England).
Chicago
Flanders Scott C, Kim Janet, Wilson Samuel, Braziunas Jeffrey, Greenfield Sheldon, Billimek John, Lechpammer Stanislav, Lin Daniel W, Karsh Lawrence, Quinn David I, Shevrin Daniel, Shore Neal D, Symanowski James T and Penson David F. 20180816. Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET. : Future oncology (London, England).
Harvard
Flanders S. C., Kim J., Wilson S., Braziunas J., Greenfield S., Billimek J., Lechpammer S., Lin D. W., Karsh L., Quinn D. I., Shevrin D., Shore N. D., Symanowski J. T. and Penson D. F. (20180816). Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET. : Future oncology (London, England).
MLA
Flanders Scott C, Kim Janet, Wilson Samuel, Braziunas Jeffrey, Greenfield Sheldon, Billimek John, Lechpammer Stanislav, Lin Daniel W, Karsh Lawrence, Quinn David I, Shevrin Daniel, Shore Neal D, Symanowski James T and Penson David F. Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET. : Future oncology (London, England). 20180816.